With around 80 % survival of childhood and adolescent cancer, around 500.000 survivors live in Europe today and the number is increasing.

8 apr 2021 · PanCareLIFE is one of three EU funded projects built on the work of the PanCare network dealing with the late effects of cancer treatment at a ...

PanCareSurFup (PCSF) is the first pan-European project to evaluate some of the serious long-term health risks faced by survivors.

This topic will contribute to the achievement of the Mission's objective to improve the quality of life of cancer patients, survivors and their families.

29 jul 2021 · European multidisciplinary network with the aim of reducing the frequency, severity, and impact of late adverse effects by establishing high- ...

The benefit is to provide every European childhood cancer survivor with better access to care and better long-term health. The project commenced in February ...

PanCareSurFup partners carry out research studies into late effects of treatment for cancer, develop evidence-based guidelines for long-term care of childhood ...

28 aug 2024 · PanCareLIFE was a 5-year (2013-8) EU Framework 7 Programme in the Health Theme that studied the impact of treatment regimes on the long-term ...

Our late effects project grants are research grants for projects investigating the late effects of childhood cancer.

Original Research. European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer.